Neuropsychological Neurology: The Neurocognitive Impairments of Neurological Disorders

ISBN: 9781107607606 出版年：2013 页码：256 Larner Cambridge University Press

Foreword Preface Acknowledgements Part I. Cognitive Function, Neuropsychological Evaluation and Syndromes of Cognitive Impairment: 1.1. Attention 1.2. General Intelligence, IQ 1.3. Memory 1.4. Language 1.5. Perception 1.6. Praxis 1.7. Executive function - 'frontal function' 1.8. 'Bedside' neuropsychological test instruments 1.9. Normal aging 1.10. Dementia, delirium, depression 1.11. Cortical vs. subcortical dementia, thalamic dementia 1.12. Disconnection syndromes Part II. Neurodegenerative Disorders: 2.1. Alzheimer's disease (AD) 2.2. Frontotemporal lobar degenerations (FTLD) 2.3. Motor neurone disease (MND), amyotrophic lateral sclerosis (ALS) 2.4. Dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD) 2.5. Prion diseases 2.6. Mild cognitive impairment (MCI) Part III. Cerebrovascular Disease - Vascular Dementia and Vascular Cognitive Impairment: 3.1. Cortical vascular dementia, Multi-infarct dementia (MID), poststroke dementia 3.2. Subcortical vascular dementia, Binswanger's disease, lacunar state, Subcortical ischaemic vascular disease (SIVD) 3.3. Strategic infarct dementia, strategic strokes 3.4. Subarachnoid haemorrhage (SAH) 3.5. Intracranial vascular malformations 3.6. Vasculopathies 3.7. Other cerebrovascular disorders Part IV. The Epilepsies: 4.1. Epilepsy and cognitive impairment 4.2. Cognitive decline and epilepsy - shared aetiology 4.3. Seizures causing acquired cognitive impairment 4.4. Anti-epileptic drug therapy causing cognitive impairment 4.5. Treatment of cognitive problems in epilepsy Part V. Neurogenetic Disorders: 5.1. Hereditary dementias 5.2. Hereditary ataxias 5.3. Hereditary spastic paraplegia 5.4. Hereditary movement disorders 5.5. Hereditary metabolic disorders 5.6. Hereditary neurocutaneous syndromes (phakomatoses) Part VI. Inflammatory, Immune-mediated and Systemic Disorders: 6.1. Multiple sclerosis 6.2. Acute disseminated encephalomyelitis (ADEM) 6.3. Sarcoidosis 6.4. Systemic lupus erythematosus (SLE) 6.5. Sjogren's syndrome 6.6. Behcet's disease 6.7. Rheumatoid arthritis (RhA) 6.8. Scleroderma, systemic sclerosis 6.9. Relapsing polychondritis 6.10. Cerebral vasculitis 6.11. Sydenham's chorea, Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) 6.12. Limbic encephalitis 6.13. Hashimoto's encephalopathy 6.14. Erdheim-Chester disease 6.15. Bilateral vestibulopathy Part VII. Structural Brain Lesions: 7.1. Brain tumours and their treatment 7.2. Hydrocephalic dementias 7.3. Other structural lesions Part VIII. Endocrine, Metabolic, and Toxin-Related Disorders: 8.1. Endocrine disorders 8.2. Metabolic disorders 8.3. Toxin-related disorders Part IX. Infective Disorders: 9.1. Encephalitides and meningoencephalitides 9.2. Meningitides 9.3. Human immunodeficiency virus (HIV) and related conditions 9.4. Other disorders of infective aetiology Part X. Neuromuscular Disorders: 10.1. Myotonic dystrophy (Steinert disease) 10.2. Myasthenia gravis Index.